4-((2,5-DICHLOROPHENYL)AZO)-N-(2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-5-YL)-3-HYDROXYNAPHTHALENE-2-CARBOXAMIDE
UNII XTE7SG6GLQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-((2,5-dichlorophenyl)azo)-n-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxynaphthalene-2-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XTE7SG6GLQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 6992-11-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H15Cl2N5O3 NAEXAHVLTQKKCY-NVQSTNCTSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-((2,5-dichlorophenyl)azo)-n-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxynaphthalene-2-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.